Abstract
The opioid-dependent patient presents great challenges for pain management. These challenges are not limited to potential addictive behaviors. In contrast to the profound pain relieving effects of acute opioid intake, chronic opioid intake can promote a counterintuitive state of enhanced pain sensitivity. Multiple biologic mechanisms inducing opioid tolerance and hyperalgesia have recently been elucidated. The potential hyperalgesic state accompanying opioid dependence complicates pain management somewhat for acute pain and cancer pain, but it especially does so for chronic pain. Guidelines for treatment of opioid dependence in the pain patient are proposed. Treatment oriented toward the long term requires limit setting and psychologic support that go beyond simple medication management.
Similar content being viewed by others
References and Recommended Reading
Quinones MA: Drug abuse during the Civil War (1861–1865). Int J Addict 1975, 10:1007–1020.
Musto DF: Historical perspectives on alcohol and drug abuse. In Substance Abuse: A Comprehensive Textbook, edn 2. Edited by Lowinson JH, Ruiz P, Millman RB, Langrod JG. Baltimore: Williams & Wilkins; 1992:2–14.
Hawkins JA: Opium Addicts and Addictions. Danville, VA: JT Townes; 1937.
Marks RM, Sachar EJ: Undertreatment of medical inpatients with narcotic analgesics. Ann Int Med 1973, 78:173–181.
Streltzer J, Wade TC: Cultural factors in the undertreatment of postoperative pain. Psychosom Med 1981, 43:397–403.
Collett BJ: Opioid tolerance: the clinical perspective. Br J Anesth 1998, 81:58–68.
Borgland SL: Acute opioid receptor desensitization and tolerance: is there a link? Clin Exp Pharmacol Physiol 2001, 28:147–154.
Song P, Zhao ZQ: The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001, 39:281–286.
Mao J: NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev 1999, 30:289–304.
Mamiya T, Noda Y, Ren X, et al.: Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor. Br J Pharmacol 2001, 132:1111–1117.
Salmon AM, Damaj MI, Marubio LM, et al.: Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice. Nat Neurosci 2001, 4:357–358.
Pan Z, Hirakawa N, Fields HL: A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/ nociceptin. Neuron 2000, 26:515–522.
Li JY, Wong CH, Huang EY, et al.: Modulations of spinal serotonin activity affect the development of morphine tolerance. Anesth Analg 2001, 92:1563–1568.
Heinricher MM, McGaraughty S, Tortorici V: Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol 2001, 85:280–286.
Xu X-J, Yu W, Hao J-X, et al.: Opioid sensitivity in experimental central pain after spinal cord injury in rats. In Opioid Sensitivity of Chronic Noncancer Pain. Edited by Kalso E, McQuay HJ, Wiesenfeld-Hallin Z. Seattle: IASP Press; 1999:183–200.
Kissin I, Bright CA, Bradley EL Jr: Can inflammatory pain prevent the development of acute tolerance to alfentanil? Anesth Analg 2001, 92:1296–300.
Ibuki T, Dunbar SA, Yaksh TL: Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain 1997, 70:125–132.
Celerier E, Laulin JP, Corcuff JB, et al.: Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci 2001, 21:4074–4080.
Vanderah TW, Suenaga NM, Ossipov MH, et al.: Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 2001, 21:279–286. This paper, as well as others cited herein, convincingly describes how the organism develops compensatory mechanisms to counterbalance the acute effects of morphine when it is given chronically.
Li X, Angst MS, Clark JD: A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res 2001, 86:56–62.
Stinus L, Allard M, Gold L, Simmonet G: Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides 1995, 16:1235–1241.
Vanderah TW, Gardell LR, Burgess SE, et al.: Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 2000, 20:7074–7079.
Ossipov MH, Lai J, Malan TP, Porreca F: Opioid Sensitivity of Chronic Noncancer Pain. Edited by Kalso E, McQuay HJ, Wiesenfeld-Hallin Z. Seattle: IASP Press; 1999.
Mayer DJ, Mao J, Holt J, Price DD: Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 1999, 96:7731–7736.
Gorman AL, Elliott KJ, Inturrisi CE: The d- and l-isomers of methadone bind to the non-competitive site on the Nmethyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett 1997, 223:5–8.
Doverty M, White JM, Somogyi AA, et al.: Hyperalgesic responses in methadone maintenance patients. Pain 2001, 90:91–96. The previous references present the science behind the phenomenon of hyperalgesia. This paper shows that it develops in humans administered chronic opioids.
Wadhwa A, Clarke D, Goodchild CS, Young D: Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery. Anesth Analg 2001, 92:448–454.
Carr DB, Goudas LC: Acute pain. Lancet 1999, 353:2051–2058.
Jamison RN, Kauffman J, Katz NP: Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000, 19:53–62.
Manfredi PL, Gonzales GR, Cheville AL, et al.: Methadone analgesia in cancer pain patients on chronic methadone maintenance therapy. J Pain Symptom Manage 2001, 21:169–174.
Portenoy RK, Payne R: Acute and chronic pain. In Substance Abuse: A Comprehensive Textbook, edn 2. Edited by Lowinson JH, Ruiz P, Millman RB, Langrod JG. Baltimore: Williams & Wilkins; 1992:691–721.
Pollo A, Amanzio M, Arslanian A, et al.: Response expectancies in placebo analgesia and their clinical relevance. Pain 2001, 93:77–84. This paper helps us understand why our communications to pain patients can be so influential, and why different physicians’ experience can lead to widely differing conclusions.
Soderstrom CA, Smith GS, Dischinger PC, et al.: Psychoactive substance use disorders among seriously injured trauma center patients. JAMA 1997, 277:1769–1774.
Compton MA: Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J Pain Symptom Manage 1994, 9:462–473.
Sallerin-Caute B, Lazorthes Y, Deguine O, et al.: Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance? Neurosurgery 1998, 42:44–49.
Spiro H: The problems of pain. Sci Med 1995, 5:6–7.
Shorter E: Somatization and chronic pain in historic perspective. Clin Orthop 1997, 336:52–60. A fascinating review of how culture influences medical conceptions of chronic pain and its treatment.
Strassels SA, Carr DB, Meldrum M, Cousins MJ: Toward a canon of the pain and analgesia literature: a citation analysis. Anesth Analg 1999, 89:1528–533.
Pawl RP: The debate over chronic pain continues. Curr Rev Pain 2000, 4:249.
Pawl RP: Controversies surrounding reflex sympathetic dystrophy: a review article. Curr Rev Pain 2000, 4:259–267. This article and the next two document the difficulties in confirming certain chronic pain diagnoses.
Winfield JB: Psychological determinants of fibromyalgia and related syndromes. Curr Rev Pain 2000, 4:276–286.
Bell DS: Epidemic occupational pseudo-illness: the plague of acronyms. Curr Rev Pain 2000, 4:324–330.
Aronoff GM, Tota-Faucette M, Phillips L, Lawrence CN: Are pain disorder and somatization valid diagnostic entities? Curr Rev Pain 2000, 4:309–312.
McQuay HJ: Opioid use in chronic pain. Acta Anaesthesiol Scand 1997, 41:175–183.
Schofferman J: Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993, 8:279–288.
Deyo RA, Weinstein JN: Low back pain. N Engl J Med 2001, 344:363–370.
Turk DC, Rudy TE: Persistent pain and the injured worker: integrating biomedical, psychosocial, and behavioral factors in assessment. J Occup Rehabil 1991, 1:159–177.
Awerbuch MS: Whiplash in Australia: illness or injury? Med J Aust 1992, 157:193–196.
American Medical Association: Guides to the Evaluation of Permanent Impairment, edn 3 [revised]. Chicago: American Medical Association; 1990.
Bayer TL, Baer PE, Early C: Situational and psychophysiological factors in psychologically induced pain. Pain 1991, 44:45–50.
Bouckoms AJ: Chronic pain: neuropsychopharmacology and adjunctive psychiatric treatment. In Textbook of Consultation-Liaison Psychiatry. Edited by Rundell JR, Wise MG. Washington, DC: American Psychiatric Press; 1996:1006–1036.
Klapow JC, Slater MA, Patterson TL, et al.: Psychosocial factors discriminate multidimensional clinical groups of chronic low back pain patients. Pain 1995, 62:349–355.
Gureje O, Von Korff M, Simon GE, Gater R: Persistent pain and well being. JAMA 1998, 280:147–115.
Brown RL, Patterson JJ, Rounds LA, Papasouliotis O: Substance abuse among patients with chronic back pain. J Fam Pract 1997, 44:17–18.
Kouyanou K, Pither CE, Wessely S: Iatrogenic factors and chronic pain. Psychosom Med 1997, 59:597–604.
Deyo RA: Fads in the treatment of low back pain. N Engl J Med 1992, 325:1039–1040.
Longo LP, Parran T Jr, Johnson B, Kinsey W: Addiction: part II. Identification and management of the drug-seeking patient. Am Fam Physician 2000, 61:2401–2408.
McQuay HJ: How should we measure the outcome? In Opioid Sensitivity of Chronic Noncancer Pain. Edited by Kalso E, McQuay HJ, Wiesenfeld-Hallin Z. Seattle:IASP Press; 1999:371–383.
Stein C: Opioid treatment of chronic nonmalignant pain. Anesth Analg 1997, 84:912–914.
Collett BJ: Opioid tolerance: the clinical perspective. Br J Anesth 1998, 81:58–68.
Eriator I: Narcotic analgesics for chronic pain management. Curr Rev Pain 1998, 2:193–200.
Streltzer J, Eliashof BA, Kline AE, Goebert D: Chronic pain disorder following physical injury. Psychosomatics 2000, 41:227–234. This study compared injured workers who developed disproportionate chronic pain with those who did not. Opioid dependence was common in the somatoform group and rare in those with more substantial injuries.
Hadler NM: Workers with disabling back pain. N Engl J Med 1997, 337:341–343.
Turk DC, Rudy TE: Persistent pain and the injured worker: integrating biomedical, psychosocial, and behavioral factors in assessment. J Occup Rehabil 1991, 1:159–177.
Jensen MC, Brandt-Zawadzki MN, Obuchowsi N, et al.: Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994, 331:69–73.
Johnson B: Three perspectives on addiction. J Am Psychoanalytic Assoc 1999, 47:791–815.
Portenoy RK: Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996, 11:203–217.
Roth SH, Fleischmann RM, Burch FX, et al.: Around-the-clock, controlled-release oxycodone therapy for osteoarthritisrelated pain. Arch Int Med 2000, 160:853–860.
Streltzer J: Chronic pain and addiction. In Consultation-Liaison Psychiatry: 1990 and Beyond. Edited by Leigh H. New York: Plenum Press; 1994:43–51.
Streltzer J: Treatment of iatrogenic drug dependence in the general hospital. Gen Hosp Psychiat 1980, 2:262–266.
Anooshian J, Streltzer J, Goebert D: Effectiveness of a psychiatric pain clinic. Psychosomatics 1999, 40:226–232.
Buckley FP, Sizemore WA, Charlton JE: Medication management in patients with chronic non-malignant pain: a review of the use of a drug withdrawal protocol. Pain 1986, 26:153–165.
Gourlay GK, Cherry DA, Cousins MJ: A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986, 25:297–312.
Mercadante S, Sapio M, Serretta R, Caligara M: Patientcontrolled analgesia with oral methadone in cancer pain: preliminary report. Ann Oncol 1996, 7:613–617.
Verebely K, Volavka J, Mule S, Resnick R: Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharm Ther 1975, 18:180–190.
Breivik H, Rennemo F: Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients. Acta Anaesth Scand 1982, 74(suppl):135–140.
Schreiber S, Backer MM, Weizman R, Pick CG: Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice. Neurosci Lett 1997, 228:25–28.
McNairy SL, Maruta T, Ivnik RJ, et al.: Prescription medication dependence and neuropsychologic function. Pain 1984, 18:169–177.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Streltzer, J. Pain management in the opioid-dependent patient. Curr Psychiatry Rep 3, 489–496 (2001). https://doi.org/10.1007/s11920-001-0043-9
Issue Date:
DOI: https://doi.org/10.1007/s11920-001-0043-9